INDV · Indivior Pharmaceuticals, Inc. · Documents

$35.25 +0.48 (+1.38%)

Market Cap

$4.10B

118.01M

Volume · Oct 20 1.93M Avg daily vol (3M) 2.3M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2024-10-08	—
6-K	—	2024-10-03	—
6-K	—	2024-10-01	—
6-K	—	2024-10-01	—
6-K	—	2024-09-24	—
6-K	—	2024-09-17	—
6-K	—	2024-09-12	—
6-K	—	2024-09-10	—
6-K	—	2024-09-04	—
6-K	—	2024-09-03	—
6-K	—	2024-09-03	2024-09-02
6-K	—	2024-08-27	—
6-K	—	2024-08-20	—
6-K	—	2024-08-20	—
6-K	—	2024-08-14	—
6-K	—	2024-08-13	—
6-K	—	2024-08-06	—
6-K	—	2024-08-06	—
6-K	—	2024-08-01	—
6-K	—	2024-07-30	—
6-K	—	2024-07-30	—
6-K	—	2024-07-30	—
6-K	—	2024-07-30	—
6-K	—	2024-07-29	—
6-K	—	2024-07-29	—
6-K	—	2024-07-29	—
6-K	—	2024-07-29	—
6-K	—	2024-07-26	—
6-K	—	2024-07-26	—
6-K	—	2024-07-25	2024-06-30
6-K	—	2024-07-25	—
6-K	—	2024-07-23	—
6-K	—	2024-07-18	—
6-K	—	2024-07-16	—
6-K	—	2024-07-15	—
6-K	—	2024-07-12	—
6-K	—	2024-07-11	—
6-K	—	2024-07-09	—
6-K	—	2024-07-09	—
6-K	—	2024-07-05	—
6-K	—	2024-07-03	—
6-K	—	2024-07-01	—
6-K	—	2024-07-01	—
6-K	—	2024-06-28	—
6-K	—	2024-06-28	—
6-K	—	2024-06-28	—
6-K	—	2024-06-27	—
6-K	—	2024-06-27	—
6-K	—	2024-06-26	—
6-K	—	2024-06-25	—

Showing 101–150 of 386 filings

Key facts CIK 1625297 CUSIP 45579U109 13F (30d) 32 filings 32 filers Visit website Investor relations